Israpafant

Israpafant

SCHEMBL8792589

Cc1ccc(S(=O)(=O)O)cc1.Cc1nnc2n1-c1sc(CCc3ccc(CC(C)C)cc3)cc1C(c1ccccc1Cl)=N[C@H]2C

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Israpafant. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 14/20 0.57
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
OPRK1 P41145 1/20 0.38
PDE4D Q08499 1/20 0.38
TBXAS1 P24557 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Israpafant SCHEMBL121587 0.90 PTAFR (0.69) PTAFRCYP3A4ALOX15OPRK1PDE4D
Israpafant SCHEMBL8792967 0.90 PTAFR (0.69) PTAFRCYP3A4ALOX15OPRK1PDE4D
Israpafant SCHEMBL30733966 0.90 PTAFR (0.69) PTAFRCYP3A4ALOX15OPRK1PDE4D
Israpafant SCHEMBL121588 0.90 PTAFR (0.69) PTAFRCYP3A4ALOX15OPRK1PDE4D
Israpafant SCHEMBL8794591 0.90 PTAFR (0.68) PTAFRCYP3A4ALOX15OPRK1PDE4D
SCHEMBL8879780 0.86 PTAFR (0.57) PTAFRCYP3A4ALOX15OPRK1PDE4D
SCHEMBL9374585 0.84 PTAFR (0.58) PTAFRCYP3A4ALOX15OPRK1PDE4D
SCHEMBL9374425 0.82 PTAFR (0.64) PTAFRCYP3A4ALOX15OPRK1PDE4D
SCHEMBL9375379 0.82 PTAFR (0.57) PTAFRCYP3A4ALOX15OPRK1PDE4D
SCHEMBL8126816 0.82 PTAFR (0.66) PTAFRCYP3A4ALOX15OPRK1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0480455-B1 Optically active thienotriazolodiazepine compounds YOSHITOMI PHARMACEUTICAL (JP) 1997-01-22 EP claimed
US-5286858-A Antagonist of platelet activating factor YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-02-15 US claimed
EP-0480455-A1 Optically active thienotriazolodiazepine compounds YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-04-15 EP claimed
EP-0797576-A1 ALKYL SUBSTITUTED PIPERADINYL AND PIPERAZINYL ANTI-AIDS COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 1997-10-01 EP disclosed
EP-0480455-B1 Optically active thienotriazolodiazepine compounds YOSHITOMI PHARMACEUTICAL (JP) 1997-01-22 EP disclosed
US-5286858-A Antagonist of platelet activating factor YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-02-15 US disclosed
EP-0480455-A1 Optically active thienotriazolodiazepine compounds YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-04-15 EP disclosed